Rituximab and omalizumab in severe, refractory insulin allergy
- PMID: 19264698
- DOI: 10.1056/NEJMc0808282
Rituximab and omalizumab in severe, refractory insulin allergy
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical